324 filings
10-Q
2024 Q1
RVNC
Revance Therapeutics Inc
Quarterly report
9 May 24
4:33pm
8-K
RVNC
Revance Therapeutics Inc
9 May 24
Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update
4:08pm
8-K
RVNC
Revance Therapeutics Inc
3 May 24
Submission of Matters to a Vote of Security Holders
4:02pm
DEFA14A
RVNC
Revance Therapeutics Inc
21 Mar 24
Additional proxy soliciting materials
4:09pm
DEF 14A
RVNC
Revance Therapeutics Inc
Definitive proxy
21 Mar 24
4:06pm
8-K
jplvbn5i4 rj5jj0msb
5 Mar 24
Other Events
5:08pm
424B5
dw2hkutzle638rawbwjq
5 Mar 24
Prospectus supplement for primary offering
5:00pm
424B5
4cq z8nc7
4 Mar 24
Prospectus supplement for primary offering
6:39am
S-8
9n00bc
28 Feb 24
Registration of securities for employees
6:32pm
8-K
hg196 x22afm
28 Feb 24
Provides Corporate Update
4:07pm
8-K
5bjktamw p4
13 Feb 24
Departure of Directors or Certain Officers
4:28pm
8-K
sfm22p4
6 Feb 24
Departure of Directors or Certain Officers
4:04pm
8-K
0r9tpqgp7
8 Jan 24
Revance Provides Corporate Update, Preliminary Fourth Quarter and Full Year 2023 Financial Results, and Financial Outlook
8:01am
8-K
moo71k85o3xie1
15 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:04pm
S-3ASR
soqob29sc4 1b9nn
14 Nov 23
Automatic shelf registration
4:22pm
8-K
otrdlppvt0n m73p
8 Nov 23
Provides Corporate Update
4:09pm
8-K
2asah4u w2c48vmyn
19 Sep 23
Revance Provides Corporate Update at Investor Day
9:01am
8-K
mk9pqhx3bhlcvohizdwm
30 Aug 23
Other Events
7:20pm